Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

FDA
News

Amneal Pharmaceuticals’ Bevacizumab-Maly Granted FDA Approval

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=reportsSearch.process#:~:text=04/13/2022,Approval

byBenzinga Newsdesk

April 13, 2022

1 minute read

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=reportsSearch.process#:~:text=04/13/2022,Approval

United States Steel’s Debt Overview

By Benzinga Insights

Today, 11:44 PM

Shares of United States Steel (NYSE:X) moved lower by 20.06% in the past three months. Before we understand the importance of debt, let us look at how much debt United States Steel has.

News

683 Capital Management Reports In 13G Filing A 5.3% Stake In SmileDirectClub

By Benzinga Newsdesk

Today, 11:44 PM

https://www.sec.gov/Archives/edgar/data/0001775625/000101359421000695/smi13g-083021.htm

SDC

Morgan Stanley Maintains Overweight on Targa Resources, Raises Price Target to $108

By Benzinga Newsdesk

Today, 11:44 PM

Morgan Stanley analyst Robert Kad maintains Targa Resources (NYSE:TRGP) with a Overweight and raises the price target from $105 to $108.

TRGP

B of A Securities Downgrades CommScope Hldg Co to Neutral, Announces $15 Price Target

By vishwanath@benzinga.com

Today, 11:44 PM

B of A Securities analyst Tal Liani downgrades CommScope Hldg Co (NASDAQ:COMM) from Buy to Neutral and announces $15 price target.

COMM

Amneal Pharmaceuticals’ Bevacizumab-Maly Granted FDA Approval

Related Posts

United States Steel’s Debt Overview

683 Capital Management Reports In 13G Filing A 5.3% Stake In SmileDirectClub

Morgan Stanley Maintains Overweight on Targa Resources, Raises Price Target to $108

B of A Securities Downgrades CommScope Hldg Co to Neutral, Announces $15 Price Target